Publication date: September 2026 Source: Blood Red Cells & Iron, Volume 2, Issue 3 Author(s): Vinod Pullarkat, Daria V. Babushok, Carlos M. de Castro, David Dingli, Jamie L. Koprivnikar, Jaroslaw P. Maciejewski, Hannah T. D. Mattson, Jens P. Panse, Lawrence Rice, Jamile M. Shammo, Erica Shoemaker, Amanda Speller, Justin Weiss, David J. Kuter
Expert guidance on when to screen, monitor, and initiate complement inhibition therapy in patients without classical PNH. // Blood Red Cells & Iron. – URL: https://www.sciencedirect.com/science/article/pii/S3050598426000582?dgcid=rss_sd_all
Expert guidance on when to screen, monitor, and initiate complement inhibition therapy in patients without classical PNH. Blood Red Cells & Iron. https://www.sciencedirect.com/science/article/pii/S3050598426000582?dgcid=rss_sd_all
“Expert guidance on when to screen, monitor, and initiate complement inhibition therapy in patients without classical PNH.” Blood Red Cells & Iron.
@article{article88626,
title = {Expert guidance on when to screen, monitor, and initiate complement inhibition therapy in patients without classical PNH},
journal = {Blood Red Cells \& Iron},
url = {https://www.sciencedirect.com/science/article/pii/S3050598426000582?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez